Clinical trial

Antepartum Chronic Epidural Therapy (ACET) to Improve Blood Flow to the Uterus…

NCT00197340 · Hadassah Medical Organization, Other · Completed

Key facts

NCT number NCT00197340
Title Antepartum Chronic Epidural Therapy (ACET) to Improve Blood Flow to the Uterus, Placenta and Baby in Pre-Eclampsia and Intrauterine Growth Restriction
Official title Antepartum Chronic Epidural Therapy (ACET) Using Ropivacaine to Improve Uteroplacental Blood Flow in Pre-Eclampsia and Intrauterine Growth Restriction
Lead sponsor Hadassah Medical Organization, Other
Collaborators International Anesthesia Research Society (IARS)
Status Completed
Phase Phase 3
Study type Interventional
Conditions Pre-Eclampsia, Fetal Growth Retardation
Intervention type Drug
Interventions Epidural ropivacaine
Enrollment 20
Start date Aug 1, 2003
Primary completion Dec 1, 2006
Completion Dec 1, 2006
First posted Sep 20, 2005
Last update posted Jul 15, 2008
Countries Israel

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies